echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Biotechnology News > Cell Metabolism constructs a three-dimensional epigenome atlas to identify diverse causes of risk for type 2 diabetes

    Cell Metabolism constructs a three-dimensional epigenome atlas to identify diverse causes of risk for type 2 diabetes

    • Last Update: 2022-09-14
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Researchers from Children's Hospital of Philadelphia (CHOP) used advanced three-dimensional mapping techniques to identify a large number of pancreatic gene variants associated with type 2 diabetes and corresponding target gene pairings


    The results of this study were published in the journal Cell Metabolism


    Cases of type 2 diabetes are on the rise, and patients are diagnosed at an earlier


    One of the challenges in studying genetic variation is to envision the function


    "If you don't have a precise map of how genes fold together in cells, you're essentially guessing the role these gene variants play, and in this study we applied three-dimensional mapping techniques to chromosomes of highly correlated cell types, which allowed us to identify a range of genes


    In this study, the researchers used a variety of techniques to detect purified acinar, alpha, and beta cells in the human pancreas at the single-cell level, creating their three-dimensional epigenomic profiles


    One of the limitations of the paper is that these newly involved genetic variants were not fully validated in functional follow-up studies


    "Previous studies appear to support many of our findings over the course of this work, and with additional validation and imaging tools, a more aggressive pathogenesis of type 2 diabetes can be isolated at the gene level," said Dr.


    The research was supported


    Original search:

    Su et al, “3D chromatin maps of the human pancreas reveal lineage-specific regulatory architecture of T2D risk.


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.